コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sy, and extensive spinal metastasis or prior kyphoplasty.
2 would benefit from prophylactic vertebro- or kyphoplasty.
3 de bracing, exercise, and vertebroplasty and kyphoplasty.
6 height was restored in 93% of vertebrae with kyphoplasty and in 82% with vertebroplasty (P < .05).
8 ined as either vertebroplasty and/or balloon kyphoplasty (BKP), is a minimally invasive surgical trea
9 to assess the efficacy and safety of balloon kyphoplasty compared with non-surgical management for pa
12 irst month were back pain (four of 70 in the kyphoplasty group and five of 64 in the control group) a
15 26.0 at baseline to 33.4 at 1 month, in the kyphoplasty group, and by 2.0 points (0.4-3.6), from 25.
16 e were two serious adverse events related to kyphoplasty (haematoma and urinary tract infection); oth
17 -randomised trials have reported benefits of kyphoplasty in patients with cancer and vertebral compre
18 ctively evaluated the safety and efficacy of kyphoplasty in the treatment of osteolytic vertebral com
23 For painful VCFs in patients with cancer, kyphoplasty is an effective and safe treatment that rapi
25 vertebrae were randomized to be treated with kyphoplasty (n = 19) or vertebroplasty (n = 18) and were
26 ients were enrolled and randomly assigned to kyphoplasty (n=70) or non-surgical management (n=64).
27 ated minimisation randomisation algorithm to kyphoplasty or non-surgical management (control group).
31 e was a greater decrease in wedge angle with kyphoplasty than with vertebroplasty (3.1 degrees vs 1.6
32 ncrease in vertebral height was greater with kyphoplasty than with vertebroplasty (5.1 mm vs 2.3 mm,
33 by a computer-generated sequence to receive kyphoplasty treatment (n=149) or non-surgical care (n=15